Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome

Fertility and Sterility

Volumn 87, Issue 1, 2007, Pages 113-120

  Neveu, Nathalie ^a,b   Granger, Louis ^a,c   St Michel, Pierre ^a   Lavoie, Hélène B ^a,b  

^a PROCREA Cliniques   (Canada)

^b Centre Hospitalier   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

clomiphene citrate; infertility; metformin; ovulation induction; Polycystic ovary syndrome; pregnancy

Indexed keywords

CLOMIFENE CITRATE; METFORMIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; FEMALE; FEMALE INFERTILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERANDROGENISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATIENT COMPLIANCE; PREGNANCY RATE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SPONTANEOUS ABORTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CANADA; CLOMIPHENE; COMORBIDITY; DRUG COMBINATIONS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; METFORMIN; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 33845747700     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.05.069     Document Type: Article

References (40)

1. Knochenhauer E., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
2. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84 (1999) 4006-4011
3. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
4. Kauffman R.P., Baker V.M., DiMarino P., Gimpel T., and Castracane V.D. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 187 (2002) 1362-1369
5. Hugues E., Collins J., Vandekerckhove P., and Lilford R. Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea. Cochrane Database Syst Rev (2000) CD000056
6. Derman S.G., and Adashi F.Y. Induction of ovulation. Compr Ther 21 (1995) 583-589
7. The ESHRS Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 15 (2000) 1856-1864
8. Gonen Y., and Casper R.F. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Human Reprod 5 (1990) 670-674
9. Kashyap S., Wells G.A., and Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod 19 (2004) 2474-2483
10. Lord J.M., Flight I.H.K., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J 327 (2003) 951-953
11. Palomba S., Orio Jr. F., Falbo A., Manguso F., Russo T., Cascella T., et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 4068-4074
12. Lavoie H.B., Rivard M., Wilhelmy A., and Miron P. Does metformin improve pregnancy rates in women with polycystic ovarian syndrome presenting high insulin levels?. The Endocrine Society 83th Annual Meeting Program and Abstracts 384 (2001) P2-P346
13. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 (2005) S4-S36
14. Diamanti-Kandarakis E., Kouli C., Alexandraki K., and Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 1273-1276
15. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
16. Fleming R., Hopkinson Z.E., Wallace A.M., Greer I.A., and Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 87 (2002) 569-574
17. Velazquez E.M., Mendoza S., Hamer T., Saso F., and Glueck C.J. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43 (1994) 647-654
18. Velazquez E.M., Acosta A., and Mendoza S. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90 (1997) 392-395
19. Sahin Y., Yirmibes U., Kelestimur F., and Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 113 (2004) 214-220
20. Kriplani A., and Agarwal N. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome. J Reprod Med 49 (2004) 361-367
21. Vandermolen D.T., Ratts V.S., Evans W.S., Stovall D.W., Kauma S.W., and Nestler J.E. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75 (2001) 310-315
22. Baillargeon J.P., Jakubowicz D.J., Luorno M.J., Jakubowicz S., and Nestler J.E. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82 (2004) 893-902
23. Ehrmann D.A., Cavaghan M.K., Imperial J., Sturis J., Rosenfield R.L., and Polansky K.S. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 (1997) 524-530
24. Moghetti P., Castello R., Negri C., Tosi F., Perrone F., Caputo M., et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85 (2000) 139-146
25. Pirwany I.R., Yates R.W., Cameron I.T., and Fleming R. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhea. Hum Reprod 14 (1999) 2963-2968
26. Kocak M., Caliskan E., Simsir C., and Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77 (2002) 101-106
27. Heard M.J., Pierce A., Carson S.A., and Buster J.E. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 77 (2002) 669-673
28. Batukan C., and Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 265 (2001) 124-127
29. Nestler J.E., Jacubowicz D.J., Evans W.S., and Pasquali R. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med 338 (1998) 1876-1880
30. Ng E.H.Y., Wat N.M.S., and Ho P.C. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial. Hum Reprod 16 (2001) 1625-1631
31. Sturrock N.D., Lannon B., and Fay T.N. Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Clin Pharmacol 53 (2002) 469-473
32. Barbieri R.L. Metformin for the treatment of polycystic ovary syndrome. Obstet Gynecol 101 (2003) 785-793
33. Pasquali R., Gambineri A., Biscotti D., Vincennati V., Gagliardi L., Colitta D., et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85 (2000) 2767-2774
34. Crave J.C., Fimbel S., Lejeune H., Cugnardey N., Dechaud H., and Pugeat M. Effects of diet and metformin administration on sex hormone-binding-globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80 (1995) 2057-2062
35. Lord J.M., Flight I.H.K., and Norman R.J. Insulin-sensitising-drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3 (2003) CD003053
36. Gorlitsky G., Kase N., and Speroff L. Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol 51 (1978) 265-269
37. Lunenfeld B., Pariente C., Dor J., Menashe Y., Seppala M., Mortman H., et al. Modern aspects of ovulation induction. Ann N Y Acad Sci 626 (1991) 207-216
38. Kousta E., White D.M., and Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 3 (1997) 359
39. Imani B., Eijkemans M.J.C., te Velde E.R., Habbema J.D.F., and Fauser B.C.J.M. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83 (1998) 2361-2365
40. Imani B., Eijkemans M.J.C., te Velde E.R., Habbema J.D.F., and Fauser B.C.J.M. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999) 1617-1622